DSIJ Mindshare

Pharma-major, Lupin Limited, announced that it has received tentative approval for its Empagliflozin and Linagliptin tablet in the strengths of 10 mg/5 mg and 25 mg/5 mg from United States Food and Drug Administration (USFDA), to commercialise a generic version of Glyxambi tablets, of Boehringer Ingelheim Pharmaceuticals, Inc.

State-owned Bank of Maharashtra share prices was trading in the green on Friday, climbing by more than 4 per cent after the bank reported positive June quarter earnings on the back of a decline in bad loans.

The revenue from operations of Asian Paints has decreased by 42.7 per cent to Rs 2,922.66 crore from Rs 5,104.72 crore on a consolidated basis for the quarter ended June 30, 2020. The paints segment, which contributes the majority part of this revenue, saw a decrease of 42.56 per cent to Rs 2,870 crore from Rs 4,996 crore last year.

The consolidated net sales reported in Q1FY21 came in at Rs 660.56 crore, which declined by 36.52 per cent YoY from Rs 1,040.55 crore in Q1FY20.

INEOS Styrolution India informed the bourses on Friday that its promoter INEOS Styrolution APAC Pte. Ltd has decided to reject the discovered price of Rs 1,100 per equity share.